Arcellx (ACLX) Net Income Growth (1y) (2022 - 2025)
Arcellx (ACLX) Net Income Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | - |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn | 17,802.13% |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn | 59.59% |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn | -10.08% |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | - |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn | 248.37% |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn | 1,228.66% |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - | - |
| 10 | Arcellx | 6.48 Bn | 6.03 Bn | - | -23.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23.34% |
| Sep 30, 2025 | -115.65% |
| Jun 30, 2025 | -94.29% |
| Mar 31, 2025 | -765.10% |
| Dec 31, 2024 | -337.07% |
| Sep 30, 2024 | 34.24% |
| Jun 30, 2024 | -13.95% |
| Mar 31, 2024 | 73.68% |
| Dec 31, 2023 | 150.89% |
| Sep 30, 2023 | 57.65% |
| Jun 30, 2023 | 22.54% |
| Mar 31, 2023 | -5.00% |
| Dec 31, 2022 | 34.40% |
| Sep 30, 2022 | -442.65% |
| Jun 30, 2022 | -93.19% |
| Mar 31, 2022 | -130.82% |